When FDA Trust Is Broken: Lessons from the MedLink Scandal

MedDevice by Design with Mark Drlik and Ariana Wilson
Resources

When FDA Trust Is Broken: Lessons from the MedLink Scandal

Sector: Diagnostics
YouTube video thumbnail

A recent FDA announcement has sent shockwaves through the MedTech community: MedLink, a third-party test house, was found falsifying test data. The consequences? All pending FDA submissions that relied on MedLink’s data have been rejected, delaying or derailing device approvals and costing companies precious time and trust.

In this episode of MedDevice by Design, Ariana Wilson and Mark Drlik examine what happened, what it means for medical device innovators, and how the FDA’s ASCA (Accreditation Scheme for Conformity Assessment) program helps reduce regulatory risk.

The FDA discovered that MedLink had falsified testing data, compromising the integrity of submissions relying on that information. As a result, those submissions are now invalid, and the affected companies must retest their devices and resubmit, costing them months of delay and significant financial loss.

Why ASCA Accreditation Matters

To prevent this kind of disruption, the FDA established the ASCA program in 2020. Labs that receive ASCA accreditation are thoroughly vetted, giving the FDA and submitting companies greater confidence in their test results. Submissions that include ASCA-accredited data benefit from reduced review times—sometimes shaving weeks or even months off approval timelines.

The Tradeoff: Fewer Labs, Higher Costs

As of late 2024, only 47 test houses hold ASCA accreditation, limiting access for some companies. Additionally, ASCA-accredited testing can be 10% to 30% more expensive than non-accredited alternatives. Still, that investment offers peace of mind and regulatory security—especially when the risk of working with an unreliable lab is so high.

Key Takeaway: Prioritize Risk Management


This episode is a reminder of the critical role third-party labs play in the regulatory process. Choosing an ASCA-accredited lab is not just about speed; it’s about reducing risk, protecting your investment, and ensuring trust in your data.

Medical device touchscreen interface displaying real-time patient vitals (SpO2, heart rate, blood pressure) with interactive digital UI elements and clinician hand operating monitor in clinical setting

Medical device teams developing embedded and cross-platform GUIs can accelerate delivery without compromising usability or validation by choosing the right framework early and designing for performance, portability, and maintainability.

Embedded microcontroller on PCB with waveform overlay illustrating CMSIS-DSP and edge AI signal processing

Compute demands on “the edge”, like embedded sensors or remote devices. have grown significantly as AI has moved from experimentation to deployment. Medical devices are pushing more of their AI functionality onto edge hardware.

Open autoclave with medical instrument trays inside during medical device cleaning and sterilization process

Medical device cleaning is more complex than it seems. In this Bio Break episode, Nick and Nigel unpack what really goes into cleaning medical devices and why it cannot be treated like a simple wipe-down process.

Macro view of optical sensor components on a PCB used in medical device optical detectors

This blog reviews the main families of optical detectors and the major technologies in those families.